ViewRay Inc (OTCPK:VRAYQ)
$ 0.00001 0 (0%) Market Cap: - Enterprise Value: - PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

ViewRay Inc at Morgan Stanley Healthcare Conference Transcript

Sep 11, 2019 / 05:35PM GMT
Release Date Price: $3.8 (+0.26%)
David Ryan Lewis
Morgan Stanley, Research Division - MD

Let's get going here. My name is David Lewis, Medical Device Analyst here at Morgan Stanley, thanks for sticking with us here as you progress into the afternoon at Day 3 of our 2019 Healthcare Conference. It's my pleasure to have with us here the CEO of ViewRay, Scott Drake. And Scott, I thought before we get into some of the strategic questions, which I think are much more interesting fundamentally long-term, I want to try to deal with a topic at hand, obviously, which is the quarter, right?

Questions & Answers

David Ryan Lewis;Scott William Drake
Morgan Stanley, Research Division - MD;

I think the fundamental question which you've been hearing about a year, the -- there's consistent commercial momentum in this business for 4 straight quarters. And this last quarter, there was a bit of a disconnect in terms of order growth, which obviously had a significant impact on the stock price. Can we just see a breakdown of what you saw on the quarter and what changed?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot